AngioDynamics (NASDAQ: ANGO) reported Q3 EPS of ($0.03), $0.02 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $80.7 million versus the consensus estimate of $83.2 million.

GUIDANCE:

AngioDynamics sees FY2023 EPS of ($0.06)-($0.01), versus the consensus of ($0.01). AngioDynamics sees FY2023 revenue of $338-342 million, versus the consensus of $342 million.

For earnings history and earnings-related data on AngioDynamics (ANGO) click here.